# PULS

> PULS is a VC fund in Saint Charles backing Biopharma and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Saint Charles, United States
- Total investments: 1
- Last investment: Jun 2010
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/puls-gmbh
- X (Twitter): https://www.twitter.com/pulspowersupply
- Website: http://www.pulspower.com/

PULS is a VC fund in Saint Charles focused on Biopharma and Health Care. PULS is the only company worldwide focused entirely on the development and production of DIN rail power supplies. We concentrate our engineering knowledge, resources and energy on one goal: To be the best in this technology. As a result of this focus, we set standards in terms of efficiency and quality that delight our customers.

## Contacts

5 contacts available for PULS. Shizune tracks 1 team members at PULS. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/puls?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bernhard Erdl | Founder & CEO | 0 | https://shizune.co/investors/profile/bernhard-erdl |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Adenovir Pharma | Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, Umeå University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of Umeå, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). | $787K |  | Jun 15, 2010 |  |

1 of 1 investments shown.

## Co-investors
- [Augmenta](https://shizune.co/investors/profile/augmenta) — VC Fund, 1 deal together
- [Länsförsäkringar](https://shizune.co/investors/profile/lnsfrskringar-skne) — VC Fund, 1 deal together
- [Sätila Holding](https://shizune.co/investors/profile/stila-holding-ab) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Biotechnology VC Funds in Sweden](https://shizune.co/investors/biotechnology-vc-funds-sweden)
- [Biotech VC Funds in Sweden](https://shizune.co/investors/biotech-vc-funds-sweden)
- [Biotechnology Investors in Sweden](https://shizune.co/investors/biotechnology-investors-sweden)
- [Biotech Investors in Sweden](https://shizune.co/investors/biotech-investors-sweden)

## FAQ

### What does PULS invest in?

PULS invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact PULS?

Public channels for PULS include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at PULS?

The team at PULS includes Bernhard Erdl (Founder & CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co